GlassScriptPhysician profile
Bryan A Gaspard
NPI 1598043143
$3,107.29
in general payments reported to CMS, 2019-2025
35 companies · $273 in 2025
The $273 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $563 · 2020: $175 · 2021: $126 · 2022: $1,098 · 2023: $291 · 2024: $582 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,145.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,023.79 | 2019-2024 | Mild Device Kit, Yukon Oct Spinal System, Tritanium |
| Providence Medical Technology, INC. | $286.83 | 2022-2025 | |
| Medtronic, INC. | $263.82 | 2023-2025 | Mazor X System, Solitaire X, Kyphon Express II Kyphopak Tray |
| Amgen INC. | $157.25 | 2024-2025 | Evenity, Prolia |
| Irras USA, INC. | $145.99 | 2019 | |
| Corelink, LLC | $140.48 | 2019 | |
| Radius Health, INC. | $123.77 | 2019-2020 | |
| Kls-Martin L.P. | $85.08 | 2020-2024 | |
| Innovation Technologies INC | $77.31 | 2024-2025 | Irrisept |
| Gt Medical Technologies, INC | $55.77 | 2021 | |
| Arbor Pharmaceuticals, INC. | $55.55 | 2019-2022 | |
| Integra Lifesciences Corporation | $54.48 | 2020-2022 | |
| Boston Scientific Corporation | $45.73 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Si-Bone, INC. | $43.05 | 2019-2023 | |
| Abbott Laboratories | $41.13 | 2019-2025 | Proclaim |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $40.98 | 2019-2022 | |
| Davol INC. | $37.06 | 2021-2024 | Channel Drain |
| Portola Pharmaceuticals, LLC | $35.16 | 2019 | |
| Depuy Synthes Sales INC. | $34.82 | 2020 | |
| Arteriocyte Medical Systems, INC. | $34.12 | 2024 | Magellan |
| Cerapedics INC. | $27.08 | 2022 | |
| Smith+Nephew, INC. | $26.93 | 2021-2022 | |
| Kerecis Limited | $25.69 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Ipsen Biopharmaceuticals, INC | $25.01 | 2023 | Dysport |
| Medtronic USA, INC. | $22.53 | 2019 | |
| Biogen, INC. | $22.17 | 2024 | Skyclarys |
| Lundbeck LLC | $22.16 | 2022 | |
| Wound Management Technologies, INC | $21.00 | 2019 | |
| Spineology INC. | $20.84 | 2024-2025 | Optimesh Expandable Interbody Fusion System |
| Xeris Pharmaceuticals, INC. | $20.70 | 2022 | |
| Penumbra, INC. | $20.54 | 2019 | |
| Baxter Healthcare | $18.91 | 2019 | |
| Convatec INC. | $18.89 | 2024 | |
| Solventum Corporation | $16.58 | 2024 | Prevena |
| Sanara Medtech INC. | $16.09 | 2023 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Gaspard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.